Lasso Peptides: Heterologous Production and Potential Medical Application
Authors:
Open Access
- 28 September 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 8, 571165
Abstract
Lasso peptides are natural products found in bacteria. They belong to a specific family of ribosomally-synthesized and posttranslationally-modified peptides with an unusual lasso structure. Lasso peptides possess remarkable thermal and proteolytic stability and various biological activities, such as antimicrobial activity, enzyme inhibition, receptor blocking, anticancer properties and HIV antagonism. They have promising potential therapeutic effects on gastrointestinal diseases, tuberculosis, Alzheimer’s disease, cardiovascular disease, fungal infections and cancer. Lasso peptides with high stability have been shown to be good carriers for other bioactive peptides. These make them attractive candidates for pharmaceutical research. This review aimed to describe the strategies used for the heterologous production of lasso peptides. Also, it indicated their therapeutical potential and their capacity to use as an efficient scaffold for epitope grafting.Keywords
Funding Information
- National Natural Science Foundation of China
- Changzhou Municipal Science and Technology Bureau
This publication has 105 references indexed in Scilit:
- The Astexin-1 Lasso Peptides: Biosynthesis, Stability, and Structural StudiesChemistry & Biology, 2013
- Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclatureNatural Product Reports, 2012
- Precursor-centric genome-mining approach for lasso peptide discoveryProceedings of the National Academy of Sciences, 2012
- The role of a conserved threonine residue in the leader peptide of lasso peptide precursorsChemical Communications, 2011
- The Antibacterial Threaded-lasso Peptide Capistruin Inhibits Bacterial RNA PolymeraseJournal of Molecular Biology, 2011
- Sequence Diversity in the Lasso Peptide Framework: Discovery of Functional Microcin J25 Variants with Multiple Amino Acid SubstitutionsJournal of the American Chemical Society, 2011
- Lariatins, Novel Anti-mycobacterial Peptides with a Lasso Structure, Produced by Rhodococcus jostii K01-B0171The Journal of Antibiotics, 2007
- Growth-Phase-Dependent Expression of the Cyclopeptide Antibiotic Microcin J25Journal of Bacteriology, 2001
- Aborycin – A Tricyclic 21‐Peptide Antibiotic Isolated from Streptomyces griseoflavusEuropean Journal of Organic Chemistry, 1994
- Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with alzheimer's diseaseCellular and Molecular Life Sciences, 1990